Posted by Michael Wonder on 29 May 2025
Pfizer and BioNTech submit EMA application for COVID-19 vaccine targeting LP.8.1 for 2025-2026 season
28 May 2025 - 2025 -- Pfizer and BioNTech today announced that they have submitted a regulatory application to the EMA for approval of Comirnaty for the 2025-2026 season, targeting the LP.8.1 strain.
The submission follows the recommendation by the EMA’s Emergency Task Force to update the COVID-19 vaccine composition for the coming season to target the LP.8.1 strain.
